Cargando…

ALK阳性非小细胞肺癌的诊断

The anaplastic lymphoma kinase (ALK) gene rearrangement is a driver gene of non-small cell lung cancer (NSCLC). Positive expression of ALK gene rearrangement has been considered a molecular subtype of NSCLC, that there are special pathological characteristics and clinical prognosis. Furthermore, the...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999849/
https://www.ncbi.nlm.nih.gov/pubmed/25676397
http://dx.doi.org/10.3779/j.issn.1009-3419.2015.02.02
_version_ 1783331530875076608
collection PubMed
description The anaplastic lymphoma kinase (ALK) gene rearrangement is a driver gene of non-small cell lung cancer (NSCLC). Positive expression of ALK gene rearrangement has been considered a molecular subtype of NSCLC, that there are special pathological characteristics and clinical prognosis. Furthermore, the tyrosine kinase inhibitor has demonstrated high effective in treating ALK positive NSCLC patients. Thus making molecular diagnostic testing for ALK expression is an important step in the process of pathological diagnosis. Currently, many detecting ALK expression assays are available or in development, clinical pathologists focus on how to choose the best method for routine diagnosis of lung cancer. There are many domestic and international authoritative guidelines recommend ALK detecting assays, technological process and relative standard. In the current review, we summarize the diagnostic tests available and the special sample types that could be used to identify patients with ALK-positive NSCLC.
format Online
Article
Text
id pubmed-5999849
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher 中国肺癌杂志编辑部
record_format MEDLINE/PubMed
spelling pubmed-59998492018-07-06 ALK阳性非小细胞肺癌的诊断 Zhongguo Fei Ai Za Zhi Alk阳性nsclc诊治 The anaplastic lymphoma kinase (ALK) gene rearrangement is a driver gene of non-small cell lung cancer (NSCLC). Positive expression of ALK gene rearrangement has been considered a molecular subtype of NSCLC, that there are special pathological characteristics and clinical prognosis. Furthermore, the tyrosine kinase inhibitor has demonstrated high effective in treating ALK positive NSCLC patients. Thus making molecular diagnostic testing for ALK expression is an important step in the process of pathological diagnosis. Currently, many detecting ALK expression assays are available or in development, clinical pathologists focus on how to choose the best method for routine diagnosis of lung cancer. There are many domestic and international authoritative guidelines recommend ALK detecting assays, technological process and relative standard. In the current review, we summarize the diagnostic tests available and the special sample types that could be used to identify patients with ALK-positive NSCLC. 中国肺癌杂志编辑部 2015-02-20 /pmc/articles/PMC5999849/ /pubmed/25676397 http://dx.doi.org/10.3779/j.issn.1009-3419.2015.02.02 Text en 版权所有©《中国肺癌杂志》编辑部2015 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/
spellingShingle Alk阳性nsclc诊治
ALK阳性非小细胞肺癌的诊断
title ALK阳性非小细胞肺癌的诊断
title_full ALK阳性非小细胞肺癌的诊断
title_fullStr ALK阳性非小细胞肺癌的诊断
title_full_unstemmed ALK阳性非小细胞肺癌的诊断
title_short ALK阳性非小细胞肺癌的诊断
title_sort alk阳性非小细胞肺癌的诊断
topic Alk阳性nsclc诊治
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999849/
https://www.ncbi.nlm.nih.gov/pubmed/25676397
http://dx.doi.org/10.3779/j.issn.1009-3419.2015.02.02
work_keys_str_mv AT alkyángxìngfēixiǎoxìbāofèiáidezhěnduàn
AT alkyángxìngfēixiǎoxìbāofèiáidezhěnduàn
AT alkyángxìngfēixiǎoxìbāofèiáidezhěnduàn